Welcome to CDC stacks |
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
Updated ACIP recommendations for use of hepatitis A vaccine and immune globulin for post-exposure prophylaxis and for international travelers
Filetype[PDF-515.37 KB]


Details:
  • Supporting Files:
    No Additional Files
    1. Hepatitis vaccines
      Personal Author:
      Reingold, Arthur
      Corporate Authors:
      United States. Advisory Committee on Immunization Practices. Hepatitis Vaccines Work Group.
      Conference Authors:
      United States. Advisory Committee on Immunization Practices. Meeting (2017 June 21-22 : Atlanta, GA)
      Published Date:
      7/12/2017
      Series:
      ACIP meeting Hepatits Vaccines
      Description:
      Presentations June 2017 Day 1hepatitis-01-reingold.pdf
      File Type:
      Filetype[PDF - 260.61 KB]
    2. Cost-effectiveness analysis of catch-up hepatitis A vaccination among unvaccinated/partially-vaccinated children
      Personal Author:
      Rein, David B.
      Corporate Authors:
      National Opinion Research Center‏.
      Conference Authors:
      United States. Advisory Committee on Immunization Practices. Meeting (2017 June 21-22 : Atlanta, GA)
      Published Date:
      7/13/2017
      Series:
      ACIP meeting Hepatits Vaccines
      Description:
      Presentations June 2017 Dayhepatitis-03-rein.pdf
      File Type:
      Filetype[PDF - 624.90 KB]
    3. Hepatitis A vaccine background
      Personal Author:
      Nelson, Noele P.
      Corporate Authors:
      United States. Advisory Committee on Immunization Practices. Hepatitis Vaccines Work Group.
      Conference Authors:
      United States. Advisory Committee on Immunization Practices. Meeting (2017 June 21-22 : Atlanta, GA)
      Published Date:
      7/26/2017
      Series:
      ACIP meeting Hepatits Vaccines
      Description:
      Presentations June 2017 Day 1hepatitis-02-nelson.pdf
      File Type:
      Filetype[PDF - 1.50 MB]
    4. Updated ACIP routine recommendations for use of hepatitis A vaccine
      Personal Author:
      Nelson, Noele P.
      Corporate Authors:
      United States. Advisory Committee on Immunization Practices. Hepatitis Vaccines Work Group.
      Conference Authors:
      United States. Advisory Committee on Immunization Practices. Meeting (2017 June 21-22 : Atlanta, GA)
      Published Date:
      7/13/2017
      Series:
      ACIP meeting Hepatits Vaccines
      Description:
      Presentations June 2017 Day 1hepatitis-04-nelson.pdf
      File Type:
      Filetype[PDF - 315.82 KB]
    5. Overview of two economic models that assess the cost-effectiveness of herpes zoster vaccinations
      Personal Author:
      Leidner, Andrew J.
      Corporate Authors:
      Berry Technology Solutions.
      Conference Authors:
      United States. Advisory Committee on Immunization Practices. Meeting (2017 June 21-22 : Atlanta, GA)
      Published Date:
      7/17/2017
      Series:
      ACIP meeting Hepatits Vaccines
      Description:
      Presentations June 2017 Day 1Agenda lists presentation as: Cost effectiveness modelszoster-04-leidner.pdf
      File Type:
      Filetype[PDF - 215.92 KB]
    6. Grading of Recommendations Assessment, Development and Evaluation (GRADE): live attenuated herpes zoster vaccine (ZVL)
      Personal Author:
      Guo, Angela
      Corporate Authors:
      National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases.
      Conference Authors:
      United States. Advisory Committee on Immunization Practices. Meeting (2017 June 21-22 : Atlanta, GA)
      Published Date:
      7/14/2017
      Series:
      ACIP meeting Hepatits Vaccines
      Description:
      Presentations June 2017 Day 1Agenda lists as: ZostavaxGRADEzoster-02-guo.pdf
      File Type:
      Filetype[PDF - 1.13 MB]
You May Also Like:
  1. Update: Recommendations of the Advisory Committee on Immunization practices for use of hepatitis A vaccine for postexposure prophylaxis and for preexposure prophylaxis for international travel
    Personal Author:
    Nelson, Noele P.; Link-Gelles, Ruth; Hofmeister, Megan G.; Romero, José R.; Moore, Kelly L.; Ward, John W.; Schillie, Sarah F.;
    Corporate Authors:
    United States. Advisory Committee on Immunization Practices.. National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (U.S.). Division of Viral Hepatitis..
    Published Date:
    Nov 02 2018
    Source:
    MMWR Morb Mortal Wkly Rep. 67(43):1216-1220
    Description:
    Postexposure prophylaxis (PEP) with hepatitis A (HepA) vaccine or immune globulin (IG) effectively prevents infection with hepatitis A virus (HAV) when administered within 2 weeks of exposure. Preexposure prophylaxis against HAV infection through the...
    File Type:
    Filetype[PDF - 109.44 KB]
  2. Considerations for use of hepatitis A vaccines for post-exposure prophylaxis and international travel
    Personal Author:
    Nelson, Noele
    Corporate Authors:
    National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (U.S.). United States. Advisory Committee on Immunization Practices. Hepatitis Vaccines Work Group..
    Conference Authors:
    United States. Advisory Committee on Immunization Practices. Meeting (2018 February 21-22 : Atlanta, GA)
    Published Date:
    4/9/18
    Series:
    ACIP meeting Hepatitis Vaccines
    Description:
    Presentations February 2018 Day 1Publication date from document properties.Hepatitis-04a-Nelson-508.pdf
    File Type:
    Filetype[PDF - 714.17 KB]
  3. Updated Dosing Instructions for Immune Globulin (Human) GamaSTAN S/D for Hepatitis A Virus Prophylaxis
    Personal Author:
    Nelson, Noele P.
    Corporate Authors:
    National Center for HIV, Viral Hepatitis, STD, and TB Prevention (U.S.). Division of Viral Hepatitis.
    Published Date:
    Sep 15 2017
    Source:
    MMWR Morb Mortal Wkly Rep. 66(36):959-960.
    Description:
    GamaSTAN S/D (Grifols Therapeutics, Inc., Research Triangle Park, North Carolina) is a sterile, preservative-free solution of immune globulin (IG) for intramuscular administration and is used for prophylaxis against disease caused by infection with h...
    File Type:
    Filetype[PDF - 117.55 KB]
  4. Update: Recommendations of the Advisory Committee on Immunization Practices for Use of Hepatitis A Vaccine for Postexposure Prophylaxis and for Preexposure Prophylaxis for International Travel
    Personal Author:
    Nelson NP, Link-Gelles R, Hofmeister MG, et al.
    Corporate Authors:
    Centers for Disease Control and Prevention (U.S.)
    Published Date:
    November 2, 2018
    Series:
    MMWR. Morbidity and mortality weekly report ; v. 67, no. 43
    Description:
    Postexposure prophylaxis (PEP) with hepatitis A (HepA)
    Status:
    current
    File Type:
    Filetype[PDF - 114.31 KB]
  5. General recommendations on immunization; recommendations of the Advisory Committee on Immunizations Practices (ACIP)
    Personal Author:
    Hadler, Stephen C.; Hutchins, Sonja S.; LeBaron, Charles W.; Watson, John C.; Williams, Walter W.;
    Corporate Authors:
    Centers for Disease Control and Prevention (U.S.), Immunization Practices Advisory Committee.. Centers for Disease Control and Prevention (U.S.).
    Published Date:
    January 28, 1994
    Series:
    MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports ; v. 43, no. RR-1
    Description:
    This revision of the General Recommendations on Immunization updates the 1989 statement. Changes in the immunization schedule for infants and children include recommendations that the third dose of oral polio vaccine be administered routinely at 6 mo...
    File Type:
    Filetype[PDF - 443.35 KB]